ThirtyFiveBio is an early-stage drug discovery company that was established in 2021 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs.

Based in Oxford, UK, the company is founded upon a deep understanding of the biology of GPR35. We are currently engaged in a fully enabled drug discovery program to identify novel small-molecule modulators of GPR35

Biotechnology

Pharmaceutical

ThirtyFiveBio

James Westcott

Stuart Hughes

Lisa Shoesmith

Josselin Caradec

Mitul Patel

Andrea Nisbet

Shelley Cook

The Leadership Team at ThirtyFiveBio is responsible for steering the company's strategic direction, overseeing operational management, and driving the core mission of discovering novel small-molecule modulators of GPR35. The team, comprised of the CEO, Chief Operating Officer, and a Co-founder, leverages their extensive experience in the pharmaceutical and biotech sectors to ensure the successful execution of the company's drug discovery programs.

Leadership Team

Management and Operations Team

Leadership Team

About

Team members

Other teams at ThirtyFiveBio

Management and Operations Team